Skip directly to content

Oncology

on Thu, 08/24/2017 - 12:25

 Experts attribute this growth to several causes, such as the emergence of successful screening programmes, longer human lifespans and lifestyle factors such as tobacco addiction.i

Based on current trends in Malaysia, it is predicted that 57,000 new cancer cases will be seen every year by 2025, with half the resulting deaths occurring in people aged 30-69 yearsii. While cancer therapies have advanced significantly in a relatively short span of time, the key to successful treatment lies in early detection and treatment.iii To support the need for greater awareness and regular screening, Pfizer works with healthcare professionals to provide educational material and helped the Malaysian Oncological Society (MOS) to develop two resources which are available for free from the Society website: the HOPE Handbook for newly-diagnosed patients and HOPE 2 Handbook targeted at caregivers.

Pfizer’s experience in cancer therapy dates back to the 1970s and has been continually refined. Today, Pfizer uses genetic engineering to develop personalised, precision medication which shrinks cancer cells more effectively, giving patients improved outcomes with fewer side effects.

References

i. Cancer Research UK. Why are cancer rates increasing?, http://scienceblog.cancerresearchuk.org/2015/02/04/why-are-cancer-rates-...

ii. National Cancer Society Malaysia (NCSM). Cancer control plan “needs efforts from all ministries”, http://www.cancer.org.my/cancer-control-plan-needs-efforts-from-all-mini...

iii. World Health Organization. Cancer Control Module, http://www.who.int/cancer/modules/Early%20Detection%20Module%203.pdf